Anand Saggar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anand Saggar has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Kshitij Mankad
Department of Neuroradiology, Great Ormond Street Hospital NHS Foundation Trust, London, UK
2 shared publications - Maria Kinali
Chelsea and Westminster NHS Foundation Trust
2 shared publications - Christos Fokoloros
20Mastocytosis Clinic, Allergy Unit, 2nd Department of Dermatology & Venereology, University of Athens, Attikon University Hospital, Athens, Greece
1 shared publication Clare Wilson
Department of Paediatric Ophthalmology, Chelsea and Westminster NHS Foundation Trust, London, United Kingdom
1 shared publication- David McCormick
The Portland Hospital for Women and Children, 205-209 Great Portland St, London, W1W 5AH, United Kingdom; Department of Paediatrics, King's College Hospital, Denmark Hill, London, SE5 9RS, United Kingdom
1 shared publication - Efterpi Pavlidou
Department of Speech and Language Therapy, University of Ioannina, 4th km of Ioannina-Athens National Road, 45500 Ioannina, Greece
1 shared publication
Latest Publications
- 1 March 2017
- Published by Elsevier in Brain and Development
- Vol. 39 (3) , 271-274
A novel PLP1 mutation associated with optic nerve enlargement in two siblings with Pelizaeus–Merzbacher disease: A new MRI finding
- 1 March 2017
- Published by Elsevier in Brain and Development
- Vol. 39 (3) , 271-274
A novel PLP1 mutation associated with optic nerve enlargement in two siblings with Pelizaeus–Merzbacher disease: A new MRI finding
- 7 October 2014
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 174 (4) , 557-563
Zellweger syndrome and secondary mitochondrial myopathy
Defects in peroxisomes such as those associated with Zellweger syndrome (ZS) can influence diverse intracellular metabolic pathways, including mitochondrial functioning. We report on an 8-month-old female infant and a 6-month-old female infant with typical clinical, radiological and laboratory features of Zellweger syndrome; light microscopic and ultrastructural evidence of mitochondrial pathology in their muscle biopsies; and homozygous pathogenic mutations of the PEX16 gene (c.460 + 5G > A) and the PEX 12 gene (c.888_889 del p.Leu297Thrfs*12), respectively. Additionally, mitochondrial respiratory chain enzymology analysis in the first girl showed a mildly low activity in complexes II–III and IV. We also review five children previously reported in the literature with a presumptive diagnosis of ZS and additional mitochondrial findings in their muscle biopsies. In conclusion, this is the first study of patients with a molecularly confirmed peroxisomal disorder with features of a concomitant mitochondrial myopathy and underscores the role of secondary mitochondrial dysfunction in Zellweger syndrome, potentially contributing to the clinical phenotype.
- 7 October 2014
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 174 (4) , 557-563
Zellweger syndrome and secondary mitochondrial myopathy
Defects in peroxisomes such as those associated with Zellweger syndrome (ZS) can influence diverse intracellular metabolic pathways, including mitochondrial functioning. We report on an 8-month-old female infant and a 6-month-old female infant with typical clinical, radiological and laboratory features of Zellweger syndrome; light microscopic and ultrastructural evidence of mitochondrial pathology in their muscle biopsies; and homozygous pathogenic mutations of the PEX16 gene (c.460 + 5G > A) and the PEX 12 gene (c.888_889 del p.Leu297Thrfs*12), respectively. Additionally, mitochondrial respiratory chain enzymology analysis in the first girl showed a mildly low activity in complexes II–III and IV. We also review five children previously reported in the literature with a presumptive diagnosis of ZS and additional mitochondrial findings in their muscle biopsies. In conclusion, this is the first study of patients with a molecularly confirmed peroxisomal disorder with features of a concomitant mitochondrial myopathy and underscores the role of secondary mitochondrial dysfunction in Zellweger syndrome, potentially contributing to the clinical phenotype.